Nabi Biopharmaceuticals (NABI) Announces Adjournment of Special Meeting of Stockholders Until October 22, 2012
9/25/2012 9:36:19 AM
ROCKVILLE, Md., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that its Special Meeting of Stockholders scheduled for September 24, 2012 has been adjourned to provide additional time to solicit proxies to approve the proposals (the "Proposals") set forth in Nabi's definitive proxy materials dated August 7, 2012, filed by Nabi with the U.S. Securities and Exchange Commission (the "SEC") in connection with the proposed business combination transaction between Nabi and Biota Holdings Limited (ASX:BTA.AX) (the "Transaction"). Nabi stated that it had convened the Special Meeting as originally scheduled but adjourned the meeting due to the absence of a quorum. The Special Meeting will be reconvened at The Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda, Maryland on October 22, 2012, at 4:30 p.m. local time.
comments powered by